D3b News & Announcements

The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.

The Center for Precision Medicine for High-risk Pediatric Cancer Frontier Program builds upon ongoing precision medicine efforts across CHOP departments to define and expand treatment options.

U.S. News & World Report ranks CHOP No. 1 in region, and we’re proud to have eight specialties ranked in the top five.

This week In the News, the Division of Neonatology is re-selected as a Neonatal Research Network Center, and researchers develop the first pediatric brain tumor atlas.

Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.

Cassie Kline, MD, MAS, and Jessica Foster, MD, received a seed grant to study CAR T-cell and radiotherapy for diffuse midline gliomas.

Ingo Helbig, MD, discusses the Arcus Omics Data launch at CHOP in a Q&A.

An update on the milestones reached to advance pediatric brain tumor research, driving forward the efforts of CHOP’s Neuroscience Center.

Children’s Hospital of Philadelphia has a leading role in the NCI’s plan to streamline drug development for childhood cancers.

Neuro-oncologist Jessica Foster MD, is investigating chimeric antigen receptor (CAR) T-cell therapy for brain tumors.

In the final installment of our Women in STEM series, six more scientists share their advice for aspiring researchers.

Whole genome sequencing for thousands of brain tumor samples will give the D³b team insight into devastating pediatric cancers.

In this project, researchers will study thousands of tissue samples, which will provide an enormous level of insight into childhood cancer.

A rare disease hack-a-thon leads to an unusual collaboration between D3b’s bioinformaticians, including Adam Resnick, PhD, and American Airlines’ software engineers.

INCLUDE DCC has launched its website to provide information and updates on the Down syndrome research data hub. Visit includedcc.org.

The Mitochondria and Cancer Connections (MC2) Research Program will study how cancer cells find the energy to grow and ways to prevent their return.

This week’s roundup features new partnerships, novel findings, and exciting approaches to diagnosing rare conditions.

Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.

A clinical research coordinator builds strength, finds community, and develops well-being with high intensity interval training.

This week’s news round-up highlights several researcher awards, and funding for D3B and neuroblastoma research

CHOP and partners develop a world-class resource for data sharing, data access, and integrative analysis in Down syndrome.